These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1836019)

  • 21. Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington's disease.
    Cicchetti F; Gould PV; Parent A
    Brain Res; 1996 Aug; 730(1-2):232-7. PubMed ID: 8883909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice.
    van Dellen A; Welch J; Dixon RM; Cordery P; York D; Styles P; Blakemore C; Hannan AJ
    Neuroreport; 2000 Nov; 11(17):3751-7. PubMed ID: 11117485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons.
    Cicchetti F; Parent A
    Mov Disord; 1996 Nov; 11(6):619-26. PubMed ID: 8914086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease.
    Pérez-Navarro E; Akerud P; Marco S; Canals JM; Tolosa E; Arenas E; Alberch J
    Neuroscience; 2000; 98(1):89-96. PubMed ID: 10858615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia.
    Reiner A; Shelby E; Wang H; Demarch Z; Deng Y; Guley NH; Hogg V; Roxburgh R; Tippett LJ; Waldvogel HJ; Faull RL
    Mov Disord; 2013 Oct; 28(12):1691-9. PubMed ID: 24014043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemically defined neuron groups and their subpopulations in the glomerular layer of the rat main olfactory bulb--II. Prominent differences in the intraglomerular dendritic arborization and their relationship to olfactory nerve terminals.
    Kosaka K; Toida K; Margolis FL; Kosaka T
    Neuroscience; 1997 Feb; 76(3):775-86. PubMed ID: 9135050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofilament and neural cell adhesion molecule immunocytochemistry of Huntington's disease striatum.
    Nihei K; Kowall NW
    Ann Neurol; 1992 Jan; 31(1):59-63. PubMed ID: 1531909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substance P and substance P receptor histochemistry in human neurodegenerative diseases.
    Kowall NW; Quigley BJ; Krause JE; Lu F; Kosofsky BE; Ferrante RJ
    Regul Pept; 1993 Jul; 46(1-2):174-85. PubMed ID: 7692486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic morphine increases calbindin D28k in rat striatum: possible NMDA receptor involvement.
    Garcia MM; Harlan RE
    Neuroreport; 1993 Oct; 5(1):65-8. PubMed ID: 8280862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease.
    Schmidt ME; Buren C; Mackay JP; Cheung D; Dal Cengio L; Raymond LA; Hayden MR
    BMC Biol; 2018 Jun; 16(1):58. PubMed ID: 29945611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calbindin-D28k in nerve cell nuclei.
    German DC; Ng MC; Liang CL; McMahon A; Iacopino AM
    Neuroscience; 1997 Dec; 81(3):735-43. PubMed ID: 9316025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
    Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B
    Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease.
    Selden N; Geula C; Hersh L; Mesulam MM
    Neuroscience; 1994 Jun; 60(3):621-36. PubMed ID: 7523983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative loss of the striatal striosome compartment, defined by calbindin-D28k immunostaining, following developmental hypoxic-ischemic injury.
    Burke RE; Baimbridge KG
    Neuroscience; 1993 Sep; 56(2):305-15. PubMed ID: 8247262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calbindin-D28k immunoreactive neurons form two populations in the rat nucleus accumbens: a compartmental study.
    Hussain Z; Totterdell S
    Brain Res; 1994 Sep; 656(1):191-8. PubMed ID: 7804837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease.
    Guo Z; Rudow G; Pletnikova O; Codispoti KE; Orr BA; Crain BJ; Duan W; Margolis RL; Rosenblatt A; Ross CA; Troncoso JC
    Mov Disord; 2012 Sep; 27(11):1379-86. PubMed ID: 22975850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
    Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
    J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.
    Yamada T; McGeer PL; Baimbridge KG; McGeer EG
    Brain Res; 1990 Sep; 526(2):303-7. PubMed ID: 2257487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility.
    Cherubini M; Ginés S
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1063-1068. PubMed ID: 27514446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.